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doi:10.1016/j.jtcvs.2006.02.008ackground: Microwave energy is commonly used on the beating heart to create
esions for the surgical treatment of atrial fibrillation. However, lesion transmurality
s likely to depend on several factors including tissue thickness and blood flow. This
tudy was designed to determine the effect of cavitary blood flow on transmurality
f acute atrial lesions with the FLEX 10 (Guidant Corporation, Santa Clara, Calif )
icrowave device.
ethods: Six pigs underwent median sternotomy and were placed on cardiopulmo-
ary bypass. Microwave lesions on the atrium were performed for 60 seconds at 65
atts at 4 different levels of cardiac output by varying cardiopulmonary bypass
ow rates. Cardiac output was measured with a pulmonary artery flow probe. Four
dditional lesions on 2 animals were done for 120 seconds at 65 Watts with 0.0 to
.5 L/min cardiac output. The animals were sacrificed, and tissue was stained with
,3,5-triphenyltetrazolium chloride and sectioned at 5-mm intervals. Lesion depth
nd width were determined from photomicrographs.
esults: Sixty-second lesions were transmural in 90%, 65%, 54%, and 46% of atrial
ections at cardiac output of 0.0 to 0.5 L/min, 0.6 to 1.9 L/min, 2.0 to 3.9 L/min, and
.0 L/min or greater, respectively (P  .001). When ablations were performed for
20 seconds with a cardiac output of 0.0 to 0.5 L/min, 100% of lesions were
ransmural. Lesion width was also related to cardiac output, with the widest lesions
roduced when cardiac output was 0.0 to 0.5 L/min.
onclusions: Acute microwave ablation lesion depth and width are strongly depen-
ent on the magnitude of cardiac output. Transmural lesions can be reliably
roduced on the porcine heart only while on cardiopulmonary bypass.
trial fibrillation (AF) is the most common sustained arrhythmia, occurring
in approximately 1% of the general population and in more than 10% of
patients aged more than 80 years.1,2 The gold standard for the surgi
reatment of AF, the Cox-Maze procedure, has a cure rate of more than 90% in our
xperience.3 However, the operation is technically challenging, requiring the 
tion of a complex set of incisions and reconstruction of the atria. To simplify the
urgical treatment of AF, groups have attempted to use various different energy
ources to replace the surgical lesions of the Cox-Maze procedure. Cryoablation,
adiofrequency energy (both unipolar and bipolar), ultrasound, laser, and microwave
nergy have all been used to create ablation lines on the atrium.4-11 Early results o
hese new energy sources have been encouraging, but long-term results are still
acking. Although microwave energy has been used extensively for the treatment of
F, there have been few studies performed to elucidate the optimum conditions for
reating transmural lesions.
Microwave energy creates heat within tissue by inducing oscillation of dielectricolecules, primarily water in living tissue.12 The depth of the lesion created by the
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A
CDicrowave device depends on the power, duration, and type
f antennae.13 Microwave energy can create tissue temp-
tures greater than 50°C but less than 100°C, which allows
or deep penetration without cavitation. It also results in
ven heating of tissue, which reduces the risk of tissue
harring and possible thromboembolism.14,15
Microwave energy is currently being used clinically to
reate lesions for the surgical treatment of AF. Although
icrowave energy was initially used on the arrested heart
uring concomitant valve or coronary surgery,5,7,8 several
roups are currently investigating the use of microwave for
ulmonary vein isolation without the use of cardiopulmo-
ary bypass (CPB) on the beating heart. Results of these
ingle-center experiences show a cure rate for AF of 68% to
5% at short-term follow-up up to 1 year.16,17 However,
linical experiences using this energy source were done
ithout well-designed experimental studies defining the
ose-response curve, and therefore without knowledge of
blation times or power needed to consistently reach trans-
urality on the beating heart.
A recent study from our laboratory on both the arrested
nd beating heart elucidated the dose-response curve of the
icrowave FLEX-10 device (Guidant Corporation, Santa
lara, Calif). This energy source consisted of a 26-mm
ntenna that is encased in a flexible 53.5-cm Teflon sheath
Figure 1). The antenna is adjustable within the sheath
an produce ablation lines 2 cm in length per application
ith a maximum ablation segment length of 20 cm (10  2
m segments). In this study, the device achieved transmu-
ality in 100% of ablated atrial sections when ablation times
ere 90 seconds on the arrested heart. However, on the
eating heart, only 20% of lesions reached transmurality,
egardless of the time of ablation.18 This lack of transmu-
ality on the beating heart was believed to be caused by the
eat-sink effect of circulating blood. Without transmural
esions, conduction block is not guaranteed and maintaining
he high cure rates of the Cox-Maze procedure is less likely.
Although a dose-response curve for the microwave de-
ice on the beating heart was demonstrated, previous studies
ave not defined whether the depth of the microwave energy
enetration is dependent on the magnitude of cavitary blood
ow. This study was designed to test the hypothesis that
lood flow across the endocardial surface is responsible for
he tissue cooling that limits lesion transmurality on the
eating heart. Cardiac output (CO) was used as an esti
Abbreviations and Acronyms
AF  atrial fibrillation
CO  cardiac output
CPB  cardiopulmonary bypass
TCC 2,3,5-triphenyl-tetrazolium chloridef cavitary blood flow. 1
56 The Journal of Thoracic and Cardiovascular Surgery ● Auguaterials and Methods
xperimental Protocol
ix domestic pigs weighing 50 to 70 kg were used in this study. All
nimals received humane care in compliance with the Guide for
he Care and Use of Laboratory Animals (National Academy
ress, Washington, DC). After overnight fasting, each animal was
remedicated, intubated, anesthetized, and monitored continuously
hroughout the procedure.
Four separate lesions, done at CO of baseline (prebypass), 2.0
o 3.9 L/min, 0.6 to 1.9 L/min, or 0.0 to 0.5 L/min, were randomly
ssigned to positions on each atrium. These randomized lesions
ere performed for 60 seconds at 65 Watts using the Guidant
LEX 10 microwave ablation device.
The heart was exposed through a median sternotomy. A myo-
ardial temperature probe was placed into the anterior wall of the
eft ventricle. Myocardial temperature was maintained between
6°C and 38°C. An ultrasonic flow probe (20-mm perivascular
robe, T206 Flowmeter, Transonic Systems; Ithaca, NY) was
laced around the pulmonary artery for continuous measurement
f CO. Blood pressure, animal core temperature, hematocrit, and
erum electrolytes were monitored throughout the procedure. Can-
ulae were placed in the superior and inferior vena cavae and the
orta after the administration of heparin. All lesions were applied
n the epicardial surface of the atria. Before the animal was placed
n CPB, a single 2-cm lesion corresponding to a baseline CO
prebypass) was made on both the right and left atria free wall at
site determined by preoperative randomization. The animal was
laced on CPB, and the venous return was manipulated to obtain
CO of 3.0 L/min (range 2.5-3.9 L/min). After 5 minutes of
tability a second 2-cm lesion was placed on both the right and the
eft atria in the preassigned randomized position. The third and
ourth lesions were done similarly, with a controlled CO of 1.5
/min (range 1.3-1.6 L/min) and then on full CPB, CO 0.0 L/min
range 0.0-0.5 L/min, Figure 2). The first 4 animals each had 
f 8 cardiac lesions (4 lesions on each atrium).
In the final 2 animals, additional lesions of a longer duration
120 seconds) were created while the animal was on full CPB (CO
.0-0.5 L/min). By using 2 consecutive segments on the FLEX 10
evice, 2 additional lesions (each 2 cm in length) were created on
he left atrium. Likewise, 2 lesions (each 2 cm in length) were
dded to the right atrium. The final 2 animals each had a total of
igure 1. FLEX 10 microwave device, Guidant Corporation (Santa
lara, Calif).2 cardiac lesions (6 on each atrium).
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CDistologic Assessment
t the end of the procedure, the animals were sacrificed and the
earts were removed en bloc. The myocardium was examined for
vidence of charring, tissue disruption, and thrombus formation.
he hearts were then placed in 1% 2,3,5-triphenyl-tetrazolium
hloride (TTC) solution and incubated at room temperature for 60
inutes. Each microwave lesion was sectioned at 5-mm intervals
erpendicular to the long axis of the ablation line. Sections were
igitally photographed with a 5-mm caliper for calibration. With
ommercial software (Adobe Photoshop, San Jose, Calif), lesion
idth, depth, and atrial tissue thickness were analyzed. The accu-
acy of this technique was 0.03 mm.18 The lesion depth an
idth were measured from the unstained area to the pink halo
egion surrounding each lesion. A total of 193 sections were
xamined corresponding to an ablation time of 60 seconds, and 27
ections were examined with ablation times of 120 seconds.
tatistical Analysis
ean width and depth were compared using the 1-way analysis of
ariance model. Post hoc multiple comparisons were made using
he Fisher least significant difference test. Data were expressed as
ean  standard deviation.
esults
n gross inspection, the lesions were pale and easily visible.
o tissue disruption was observed. Minimal tissue charring
as seen in lesions done on full CPB, whereas no charring
as seen when CO was greater than 0.5 L/minute. No
hrombus formation was seen in any of the ablated atria.
trial lesion depth was evaluated, as was atrial wall thick-
ess in the area of ablation and the number of transmural
igure 2. Left atrium postprocedure. A, Lesion done at 0.0 L/min.
, Lesion done at 5.0 L/min.esion cross-sections. 0
The Journal of Thoracictrial Ablations
ifty-two of 58 (90%) of atrial ablation sections done while
O was 0.0 to 0.5 L/min were transmural when the ablation
as applied for 60 seconds. The percentage of lesions that
ere transmural was inversely correlated to the level of CO
65% at CO of 0.6-1.9 L/min n  40, 54% at CO of 2.0-3.9
/min n  71, and 46% at CO of 4.0 L/min n  24).
tatistical analysis revealed that there was a significantly
igher number of lesions that were transmural in the group
n full CPB (60-second lesions) versus the other 3 groups in
hich CO was greater than 0.5 L/min (P  .01). When
blation duration was prolonged to 120 seconds, 100% of
blated atrial sections were transmural (n  27, Figure 3)
here was a trend toward significance in the number of
ransmural lesions in the group on full CPB for 120 seconds
27/27, 100%) versus the group on full CPB for 60 seconds
52/58, 90%; P  .092).
Lesion widths were similarly affected by CO. When the
O was 0.0 to 0.5 L/min, mean lesion width was 6.0  2.8
m. At CO of 0.6 to 1.9 L/min, the mean width decreased
o 4.9 1.8 mm, with a CO of 2.0 to 3.9 L/min to 5.0 1.5
m; at CO of greater than 4.0 L/min, the mean width
ecreased to only 4.4 2.0 mm. Comparison between these
roups showed that lesions were significantly wider when
n full CPB versus the other 3 groups (P  .001). The
esions were significantly wider when the CO was 0.0 to
igure 3. Lesion transmurality versus CO. Lesions done at 120
econds (left); lesions done at 60 seconds (right). *Statistical
nalysis revealed that there was a significantly higher number of
esions that were transmural in the group on full CPB (60-second
esions) versus the other 3 groups in which CO was greater than
.5 L/min (P < .01). **There was a trend toward significance in
he number of transmural lesions in the group on full CPB for 120
econds (27/27, 100%) versus the group on full CPB for 60 seconds
52/58, 90%; P  .092)..5 L/min and the lesions were done for 120 seconds: 9.7 
and Cardiovascular Surgery ● Volume 132, Number 2 357
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A
CD.9 mm (P  .001 when compared with 60-second lesions
t same CO; Figure 4).
trial Thickness
trial wall thickness at each ablation site was measured to
etermine its influence on the results. The total mean atrial
issue thickness for all lesions created was 2.62  1.31 mm
range 0.4-6.9 mm). The mean atrial wall thicknesses of
0-second lesions created at each CO were 2.7  1.4 mm
CO 0.0-0.5 L/min), 2.4  1.2 mm (CO 0.6-1.9 L/min),
.6 1.4 mm (CO 2.0-3.9 L/min), and 2.0 0.8 mm (CO
.0 L/min). The mean atrial wall thickness at the site of the
20-second lesions (CO of 0.0-0.5 L/min) was 3.4  1.5
m. The thickness of the atrial wall for the 120-second
esions was significantly greater than in all other groups
P  .02 compared with each group). The atrium was
hinnest at the site of ablations created prebypass (4.0
/min); it was statistically less than the mean atrial wall
hickness of lesions created with CO of 0.0 to 0.5 L/min
P  .04) and with CO of 2.0 to 3.9 L/min (P  .05).
omment
icrowave energy has been widely used for the surgical
reatment of AF, despite the lack of laboratory studies
escribing the specific parameters required to achieve trans-
urality in the clinical setting.5,19,20 Although good clinica
esults have been reported using this energy on both the
rrested heart and the beating heart,21,22 the clinical expe-
ience has not been based on published dose-response
urves for this technology on living myocardial tissue.
Recent work from our laboratory suggested that micro-
igure 4. Lesion width versus CO. *Comparison showed that
0-second lesions were significantly wider when on full CPB
ersus the other 3 groups (P < .001). **Lesions were significantly
ider when the CO was 0.0 to 0.5 L/min and the lesions were
one for 120 seconds: 9.7  3.9 mm (P < .001 when compared
ith 60-second lesions at same CO).ave ablation is not capable of consistently creating acute t
58 The Journal of Thoracic and Cardiovascular Surgery ● Auguransmural lesions on the beating heart.18 This has been
ypothesized to be the result of the heat-sink phenomenon
f circulating cavitary blood flow cooling the endocardial
urface. This study was designed to answer this hypothesis
nd determine the relationship between cavitary flow and
esion depth.
This acute study demonstrated that the FLEX 10 device
as capable of producing transmural atrial lesions while on
PB if cavitary flow is reduced. Ninety percent of atrial
esions created on the heart were transmural when the
avitary blood flow was minimal (on full CPB) with abla-
ion duration of 60 seconds, and 100% of lesions were
ransmural when ablation times were 120 seconds. As CO
nd cavitary blood flow increased, the percentage of trans-
ural lesions was reduced. This is consistent with the
ypothesis that the endocardial blood reservoir acts as a
eat-sink. This finding is also consistent with Gaynor and
olleagues’18 findings in which only 20% of microw
esions (even at prolonged ablation times) were transmural
n the beating heart, whereas 100% of lesions done for more
han 90 seconds were transmural when the heart was
rrested.
When the cavitary blood flow was minimal, the majority
f lesions were transmural even when ablated for only 60
econds. The lesions that did not achieve transmurality were
hose located over the trabeculated areas of the right atrium,
hich were as thick as 6.9 mm. When the cavitary blood
ow was kept at a minimum and the ablation time was
ncreased to 120 seconds, even the thickest areas of the
trium (up to 6.0 mm) achieved transmurality. The random-
zation of the lesions over the course of this study was
erformed to prevent the local variation of atrial thickness
rom being a factor in lesion transmurality. Although the
issue was significantly thicker for lesions done at 120
econds on full CPB, they were still 100% transmural.
oreover, although the atrial tissue was thinnest in the
rebypass lesions done at CO greater than 4.0 L/min, this
roup had the lowest percentage of transmural lesions.
The mean width of lesions increased from 4.4 mm to
.0 mm when the CO was decreased from greater than
.0 L/min to 0.0 to 0.5 L/min. There was also a significant
ifference between 60-second and 120-second ablations,
ith lesion width increasing to approximately 1 cm.
To avoid collateral damage the surgeon should remain
ognizant that thermal spread may extend beyond the width
f the device, particularly when ablation is performed over
xtended time while on full CPB. These lesions are wider
han those reported previously in the literature when used on
he beating heart, likely because the heat-sink effect of
irculating blood was eliminated when on full CPB, which
llowed tissues to reach a higher temperature.18
Past experience has proven that it is difficult to achieve
ransmurality on the beating heart when using a unipolar
st 2006
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A
CDblation device. Unipolar radiofrequency devices have had
imited success on both the beating and arrested heart in an
vine model.23 In addition to the circulating blood poo
he beating heart, epicardial fat was believed to be a con-
ributing negative factor in the production of transmural
esions. The results with the radiofrequency device are
orse in humans, with only 8% of lesions transmural in one
tudy.23-25 The microwave device is reported to be bette
vercoming the problem of creating lesions through fat;
owever, the cooling effect of circulating blood has re-
ained an impediment to creating transmural lesions.
Controversy remains over the necessity of creating trans-
ural lesions for an effective cure of AF. Because several
nvestigators have used microwave on the beating heart for
he treatment of AF with moderate to good results, it has
een argued that transmurality is not necessary.7,16,22,26
owever, in an acute canine model, van Brakel and col-
eagues27 showed that complete isolation was necessary
revent AF induction by triggering from an isolated area,
ven though incomplete isolation decreased AF duration
nd lengthened the AF cycle length. Because of the intrinsic
roperties of myocytes to conduct electrical impulses, the
heoretic consequence of leaving any intact tissue is signif-
cant. Furthermore, small areas of viable tissue may con-
ribute to sustaining arrhythmias such as atrial flutter.28,29
xperiments performed on isolated atria have shown that
eaving even very small gaps in ablation lines allowed the
ropagation of electrical impulses.30-33 The only guarante
f complete conduction block is a fully transmural lesion. In
ight of this, the results of this study suggest that microwave
blation should be used with caution on the beating heart. If
surgeon chooses to use this energy source to isolate
ulmonary veins, then pacing should be used to document
onduction block after the procedure.
tudy Limitations
he study has a number of limitations. First, the experi-
ents were performed in an acute model. A chronic model
ay have yielded different results, because it is possible that
here may be lesion extension with time after microwave
blation.34 However, TTC staining has been documented
e effective, reliable, and sensitive in determining the extent
f necrosis after ablation.35 Our laboratory has previousl
sed this staining method, and found that acute results with
TC staining correlated well with chronic histology.36,37
Another limitation of this study was that normal porcine
earts were used to examine the effect of microwave abla-
ion. It is possible that the pathologic states common in AF
ould alter results, especially because atrial thickness and
brosis are increased in patients with long-standing arrhyth-
ias and valvular disease. This may make transmural abla-
ion more difficult to achieve. However, with adequate
blation times and no circulating blood volume to disperse
The Journal of Thoraciche heat, it should be possible to create completely acute
ransmural lesions on even very thick atria.
Pulmonary artery flow was used as an estimate of left and
ight atria cavitary blood flow, and it may not be a precisely
ccurate reflection of regional flows (ie, right atrial append-
ge). However, it is difficult, if not impossible, to measure
egional flow velocity at the time of ablation, and this
hould serve as a rough estimate. Moreover, this study was
esigned principally to look at the effect of changes in
avitary blood flow on lesion depth, and there is no doubt
hat there was a linear relationship between cavitary atrial
lood flow and CO. Finally, observer error when determin-
ng lesion depths and widths can occur. Calipers were
lways photographed with the tissue samples, and 2 inde-
endent observers viewed all the tissue samples in an effort
o reduce this error.
onclusion
cute microwave ablation lesion depth and width are de-
endent on cavitary blood flow. The microwave device is
imited by the cooling effects of the circulating blood in the
trium because it created a lower percentage of transmural
trial lesions when the cavitary blood flow was increased
ore than 0.5 L/min. The use of CPB to decrease the
irculating cavitary blood volume made the device capable
f consistently producing acute transmural lesions on the
tria.
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